Ranbaxy Pays Record $500M To End Tainted Drug Claims
Ranbaxy Laboratories Ltd. will pay $350 million to settle a Maryland whistleblower False Claims Act suit over selling allegedly adulterated drugs to several government health care programs, plus an additional $150...To view the full article, register now.
Already a subscriber? Click here to view full article